1.A Case of Erythema Multiforme Associated with Malignant Lymphoma.
Un Cheol YEO ; Kwang Hyun CHO ; Yoo Shin LEE ; Dae Seog HEO ; Seung Chul LEE
Korean Journal of Dermatology 1990;28(5):597-601
No abstract available.
Erythema Multiforme*
;
Erythema*
;
Lymphoma*
2.Successful Immunoglobulin Treatment in Severe Cryptogenic Organizing Pneumonia Caused by Dermatomyositis.
Dong Hoon LEE ; Jee Hyun YEO ; Young Il KIM ; Seung Jun GIM ; Jang Won SOHN ; Ji Young YHI
Korean Journal of Critical Care Medicine 2015;30(3):212-217
In connective tissue diseases, autoantibodies cause pulmonary interstitial inflammation and fibrosis, and patients require treatment with an immunosuppressive agent such as a steroid. Dermatomyositis is an incurable, uncommon form of connective tissue disease that occasionally causes diffuse pulmonary inflammation leading to acute severe respiratory failure. In such cases, the prognosis is very poor despite treatment with high-dose steroid. In the present case, a 46-year-old man was admitted to our hospital with dyspnea. He was diagnosed with dermatomyositis combined with cryptogenic organizing pneumonia (COP) with respiratory failure and underwent treatment with steroid and an immunosuppressive agent, but the COP was not improved. However, the respiratory failure did improve after treatment with intravenous immunoglobulin, which therefore can be considered a treatment option in cases where steroids and immunosuppressive agents are ineffective.
Autoantibodies
;
Connective Tissue Diseases
;
Cryptogenic Organizing Pneumonia*
;
Dermatomyositis*
;
Dyspnea
;
Fibrosis
;
Humans
;
Immunoglobulins*
;
Immunosuppressive Agents
;
Inflammation
;
Lung Diseases, Interstitial
;
Middle Aged
;
Pneumonia
;
Prognosis
;
Respiratory Insufficiency
;
Steroids
3.Safety of Surgical Tracheostomy during Extracorporeal Membrane Oxygenation.
Hye Ju YEO ; Seong Hoon YOON ; Seung Eun LEE ; Doosoo JEON ; Yun Seong KIM ; Woo Hyun CHO ; Dohyung KIM
Korean Journal of Critical Care Medicine 2017;32(2):197-204
BACKGROUND: The risk of bleeding during extracorporeal membrane oxygenation (ECMO) is a potential deterrent in performing tracheostomy at many centers. To evaluate the safety of surgical tracheostomy (ST) in critically ill patients supported by ECMO, we reviewed the clinical correlation between preoperative coagulation status and bleeding complication-related ST during ECMO. METHODS: From April 1, 2012 to March 31, 2016, ST was performed on 38 patients supported by ECMO. We retrospectively reviewed and analyzed the medical records including complications related to ST. RESULTS: Heparin was administered to 23 patients (60.5%) for anticoagulation during ECMO, but 15 patients (39.5%) underwent ECMO without anticoagulation. Of the 23 patients administered anticoagulation therapy, heparin infusion was briefly paused in 13 prior to ST. The median platelet count, international normalized ratio, and activated partial thromboplastin time before ST were 126 ×109/L (range, 46 to 434 ×109/L), 1.2 (range, 1 to 2.3) and 62 seconds (27 to 114.2 seconds), respectively. No peri-procedural clotting complications related to ECMO were observed. Two patients (5.3%) suffering from ST-related major bleeding required surgical hemostasis. Minor bleeding after ST occurred in two cases (5.3%). No significant difference was found according to anticoagulation management (P = 0.723). No fatality was attributable to ST. CONCLUSIONS: The complication rates of ST in the patients supported by ECMO were low. Therefore, ST performed by an experienced operator, and with careful optimization of coagulation status, is a relatively safe procedure; the use of ST with ECMO should thus not be dismissed on account of the potential for bleeding caused by the administration of anticoagulants.
Anticoagulants
;
Critical Illness
;
Extracorporeal Membrane Oxygenation*
;
Hemorrhage
;
Hemostasis, Surgical
;
Heparin
;
Humans
;
International Normalized Ratio
;
Medical Records
;
Partial Thromboplastin Time
;
Platelet Count
;
Retrospective Studies
;
Tracheostomy*
4.Secondary nipple reconstruction using two surgical techniques
Jae-Ho CHUNG ; Da-Som KIM ; Hyun-Dong YEO ; Seung-Pil JUNG ; Seung-Ha PARK ; Eul-Sik YOON
Archives of Plastic Surgery 2021;48(6):590-598
Background:
Although the initial projection after primary nipple reconstruction is excellent, nipple projection gradually flattens in most cases due to multiple causes. Although various methods have been reported to rebuild the nipple after nipple flattening, the most effective method of secondary nipple reconstruction remains unknown. The aim of this study was to review our institution’s experiences with secondary nipple reconstruction.
Methods:
We conducted a retrospective review from March 2012 to January 2019. We performed secondary nipple reconstruction if the primary reconstructed nipple height differed by more than 6 mm from the normal nipple height. We chose the method of nipple revision according to the degree of tissue scarring and the remaining nipple projection.
Results:
We performed secondary nipple reconstruction on a total of 27 nipples, using pursestring sutures for 19 nipples and star flaps in eight nipples. The median follow-up period was 8 months (range, 6–19 months) after the final nipple reconstruction. Among the 19 nipples reconstructed using purse-string sutures, 10 (53%) demonstrated acceptable projection of more than 5 mm. Among the eight nipples reconstructed using star flaps, six (75%) showed acceptable projection of more than 5 mm. Most of the patients (73%) were satisfied (scores of 4 or 5) with the nipple reconstruction overall.
Conclusions
Few studies have presented favorable outcomes of secondary nipple reconstruction. When the star flap and purse-string suture methods were used depending on the remaining nipple height and scarring, appropriate projection could be achieved.
5.Paralytic Ileus and Prophylactic Gastrointestinal Motility Medication after Spinal Operation.
Chang Hyun OH ; Gyu Yeul JI ; Seung Hwan YOON ; Dongkeun HYUN ; Hyeong Chun PARK ; Yeo Ju KIM
Yonsei Medical Journal 2015;56(6):1627-1631
PURPOSE: To investigate the prevalence of paralytic ileus after spinal operation in the supine or prone operative position and to determine the efficacy of prophylactic gastrointestinal motility medications in preventing symptomatic paralytic ileus after a spinal operation. MATERIALS AND METHODS: All patients received spinal surgery in the supine or prone operative position. The study period was divided into two phases: first, to analyze the prevalence of radiographic and symptomatic paralytic ileus after a spinal operation, and second, to determine the therapeutic effects of prophylactic gastrointestinal motility medications (postoperative intravenous injection of scopolamine butylbromide and metoclopramide hydrochloride) on symptomatic paralytic ileus after a spinal operation. RESULTS: Basic demographic data were not different. In the first phase of this study, 27 patients (32.9%) with radiographic paralytic ileus and 11 patients (13.4%) with symptomatic paralytic ileus were observed. Radiographic paralytic ileus was more often noted in patients who underwent an operation in the prone position (p=0.044); whereas the occurrence of symptomatic paralytic ileus was not different between the supine and prone positioned patients (p=0.385). In the second phase, prophylactic medications were shown to be ineffective in preventing symptomatic paralytic ileus after spinal surgery [symptomatic paralytic ileus was observed in 11.1% (4/36) with prophylactic medication and 16.7% (5/30) with a placebo, p=0.513]. CONCLUSION: Spinal surgery in the prone position was shown to increase the likelihood of radiographic paralytic ileus occurrence, but not symptomatic paralytic ileus. Unfortunately, the prophylactic medications to prevent symptomatic paralytic ileus after spine surgery were shown to be ineffective.
Adjuvants, Anesthesia/*administration & dosage/pharmacology
;
Adult
;
Aged
;
Antiemetics/*administration & dosage/pharmacology
;
Female
;
Gastrointestinal Motility/*drug effects/physiology
;
Humans
;
Injections, Intravenous
;
Intestinal Pseudo-Obstruction/drug therapy/epidemiology/*prevention & control
;
Lumbar Vertebrae/radiography/*surgery
;
Male
;
Metoclopramide/*administration & dosage/pharmacology
;
Middle Aged
;
Postoperative Complications/epidemiology
;
Prevalence
;
Prone Position
;
Prospective Studies
;
Republic of Korea
;
Scopolamine Hydrobromide/*administration & dosage/*pharmacology
;
Spinal Fusion/*adverse effects
;
Supine Position
;
Treatment Outcome
6.Long Term Clinical Outcomes of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Single Center Study
Seong Hyun KOH ; Seung Hyun YEO ; Moo In PARK ; Kyoungwon JUNG ; Sung Eun KIM ; Won MOON ; Seun Ja PARK
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2024;24(1):64-71
Objectives:
Few studies have reported long-term follow-up after treatment of gastric mucosaassociated lymphoid tissue (MALT) lymphoma. In this single-center study, we investigated longterm treatment outcomes in patients diagnosed with gastric MALT lymphoma.
Methods:
The study included 80 patients diagnosed with gastric MALT lymphoma, who were followed up at a single center between January 2005 and December 2019 after Helicobacter pylori eradication therapy, radiotherapy, or chemotherapy. We evaluated complete remission, improvement, or recurrence of the lesion. Follow-up over >60 months was classified as long-term follow-up, and the progression-free survival rate was recorded.
Results:
Following H. pylori eradication treatment, complete remission occurred in 85.9% (55/64) of H. pylori-positive and 50.0% (3/6) of H. pylori-negative patients. All patients with gastric MALT lymphoma who did not respond to H. pylori eradication therapy (100.0% [6/6]) achieved complete remission following administration of local radiotherapy. We observed no deaths on long-term follow-up (>60 months), and the progression-free survival was 101 months.
Conclusions
In this study, patients with gastric MALT lymphoma showed excellent survival rates, progression-free survival, and prognosis on long-term follow-up. Prospective studies are warranted to determine the long-term prognosis of gastric MALT lymphoma after treatment.
7.Clinical Analysis of Auricular Benign Masses.
Su Young JUNG ; Myung Gu KIM ; Sung Hyun BOO ; Eun Kyung YEO ; Chul KWON ; Sun Kyu LEE ; Seung Geun YEO
Korean Journal of Audiology 2012;16(1):10-13
BACKGROUND AND OBJECTIVES: Auricular masses are growths on the outer ear that have not been well characterized clinically. We assessed the clinical nature and treatment of auricular benign masses in patients at our institution. SUBJECTS AND METHODS: We retrospectively identified 63 patients with auricular benign masses who underwent excision and biopsy from May 1970 to April 2011. We determined the site, cause, size, pathology and postoperative results of these auricular masses. RESULTS: Auricular benign masses occurred most commonly on the lobule (44.4%), followed by the tragus (20.6%), crus of helix (11.1%), triangular fossa (6.3%), crus of antihelix-antitragus (3.1%) and scapha (1.5%). Pathologically, the most common type of auricular mass was epidermal cysts (25.3%), followed by hypertrophic scar (12.6%), fibrous tissue-accessory ear (9.5%), chronic inflammation-nevus (7.9%), keloid (6.3%), hemangioma (4.7%), and skin tag-seborrheic keratosis (3.1%). CONCLUSIONS: The most common site of auricular benign masses is the lobule and most common pathology is an epidermal cyst.
Biopsy
;
Cicatrix, Hypertrophic
;
Ear
;
Ear, External
;
Epidermal Cyst
;
Hemangioma
;
Humans
;
Keloid
;
Keratosis
;
Retrospective Studies
;
Skin
8.Clinical Analysis of Anaplastic Thyroid Carcinoma.
Hyun Young KIM ; Ki wook CHUNG ; Hwal Woong KIM ; Yeo Kyu YOUN ; Seung Kun OH
Korean Journal of Endocrine Surgery 2001;1(2):244-249
PURPOSE: Anaplastic thyroid carcinoma is characterized with rapid growing mass of the neck and early infiltration into the surrounding tissue. Because of its advanced presentation in elderly patients with poor general condition, difficulty in diagnosis and lack of effective treatment, it is one of the most lethal cancers in human. The aim of this study was to investigate the clinicopathologic character of anaplastic thyroid carcinoma and analyze the prognostic factors affecting survivals. METHODS: Twenty patients diagnosed anaplastic thyroid carcinoma in Seoul National University Hospital between 1985 and 1999 were reviewed retrospectively. RESULTS: The most common symptom was a rapidly enlarging neck mass. Ten (55.5%) of 18 patients had a concomitant well differenciated thyroid carcinomas and 5 (27.8%) patients had benign thyroid disease on pathologic features. The median survival was 5.5 months and the 2-year survival rate was 27.3%. Among several factors analyzed, tumor size smaller than 5 cm (p<0.001), absence of distant metastases at presentation (p=0.020), patients selected for curative surgical resection (p=0.002), and postoperative radiotherapy (p=0.003) were associated with prolonged survival time. CONCLUSION: In the selected patients(tumor size <5 cm, the absence of distant metastases at presentation, young age (<55), curative surgical resection and adjuvant radiotherapy may be associated with an increased survival time.
Aged
;
Diagnosis
;
Humans
;
Neck
;
Neoplasm Metastasis
;
Radiotherapy
;
Radiotherapy, Adjuvant
;
Retrospective Studies
;
Seoul
;
Survival Rate
;
Thyroid Carcinoma, Anaplastic*
;
Thyroid Diseases
;
Thyroid Neoplasms
9.Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
Junghan SONG ; Yeo Min YOON ; Hyun Jin JUNG ; Seung Ho HONG ; Hyosoon PARK ; Jin Q KIM
Journal of Korean Medical Science 2000;15(2):146-152
An increased risk for arterial thrombosis is associated with high plasma levels of coagulation and fibrinolytic factors such as PAI-1 and FVII. In this study, the 4G/5G polymorphism in the promoter of PAI-1 gene and Arg353-->Gln polymorphism in the FVII gene were analysed in 139 normal adults and 158 patients with coronary artery disease (CAD), and their association with plasma lipid traits was investigated. There were no significant differences in the allele frequencies of PAI-1 and FVII polymorphisms between control and patient groups. The allelic distributions of both polymorphisms in Koreans were similar to those in Japanese but significantly different from those in Caucasians. In the CAD group, the 4G homozygotes of PAI-1 polymorphism showed significantly higher levels of total (p=0.0250) and LDL cholesterol (p=0.0335) with individuals having other genotypes. However, FVII polymorphism showed no association with lipid levels. In conclusion, the 4G/5G PAI-1 promoter polymorphism and Arg353-->Gln FVII polymorphism are not major genetic risk factors for CAD in Koreans. However, 4G allele of PAI-1 polymorphism revealed to be associated with the levels of cholesterol, especially LDL cholesterol levels in CAD patients.
Aged
;
Alleles
;
Apolipoproteins A/blood
;
Apolipoproteins B/blood
;
Coronary Disease/genetics*
;
Coronary Disease/blood
;
Factor VII/genetics*
;
Female
;
Genotype
;
Human
;
Korea
;
Lipoproteins, HDL Cholesterol/blood
;
Lipoproteins, LDL Cholesterol/blood
;
Male
;
Middle Age
;
Plasminogen Activator Inhibitor 1/genetics*
;
Polymorphism, Single Nucleotide*
;
Promoter Regions (Genetics)/genetics*
;
Triglycerides/blood
10.Clinical Characteristics of Respiratory Extracorporeal Life Support in Elderly Patients with Severe Acute Respiratory Distress Syndrome.
Woo Hyun CHO ; Dong Wan KIM ; Hye Ju YEO ; Seong Hoon YOON ; Seung Eun LEE ; Doo Soo JEON ; Yun Seong KIM ; Bong Soo SON ; Do Hyung KIM
Korean Journal of Critical Care Medicine 2014;29(4):266-272
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) strategy is proposed to reduce the ventilator-induced lung injury in acute respiratory distress syndrome (ARDS). As ECMO use has increased, a number of studies on prognostic factors have been published. Age is estimated to be an important prognostic factor. However, clinical evidences about ECMO use in elderly patients are limited. Therefore, we investigated clinical courses and outcomes of ECMO in elderly patients with ARDS. METHODS: We reviewed medical records of patients with severe ARDS who required ECMO support. Study patients were classified into an elderly group (> or = 65 years) and a non-elderly group (< 65 years). Baseline characteristics, ECMO related outcomes and associated factors were retrospectively analyzed according to group. RESULTS: From February 2011 to June 2013, a total of 31 patients with severe ARDS were treated with ECMO. Overall, 14 (45.2%) were weaned from ECMO, 9 (29.0%) survived to the general ward and 7 (22.6%) survived to discharge. Among the 18 elderly group patients, 7 (38.9%) were weaned from ECMO, 4 (22.2%) were survived to the general ward and 2 (11.1%) were survived to discharge. Overall intensive care unit survival was inversely correlated with concomitant acute kidney injury or septic shock. CONCLUSIONS: In this study, ECMO outcome was poor in severe ARDS patients aged over 65 years. Therefore, the routine use of ECMO in elderly patients with severe ARDS is not warranted except in highly selective cases.
Acute Kidney Injury
;
Aged*
;
Extracorporeal Membrane Oxygenation
;
Humans
;
Intensive Care Units
;
Medical Records
;
Patients' Rooms
;
Respiratory Distress Syndrome, Adult*
;
Retrospective Studies
;
Shock, Septic
;
Ventilator-Induced Lung Injury